HCA Holdings Inc (HCA) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
HCA Holdings Inc stock (HCA) is currently trading at $484.02. HCA Holdings Inc PE ratio is 17.14. HCA Holdings Inc PS ratio (Price-to-Sales) is 1.44. Analyst consensus price target for HCA is $543.05. WallStSmart rates HCA as Moderate Buy.
- HCA PE ratio analysis and historical PE chart
- HCA PS ratio (Price-to-Sales) history and trend
- HCA intrinsic value — DCF, Graham Number, EPV models
- HCA stock price prediction 2025 2026 2027 2028 2029 2030
- HCA fair value vs current price
- HCA insider transactions and insider buying
- Is HCA undervalued or overvalued?
- HCA Holdings Inc financial analysis — revenue, earnings, cash flow
- HCA Piotroski F-Score and Altman Z-Score
- HCA analyst price target and Smart Rating
HCA Holdings Inc
📊 No data available
Try selecting a different time range
HCA Intrinsic Value Analysis for Value Investors
Benjamin Graham Formula · HCA Holdings Inc (HCA)
HCA trades at a significant discount to its Graham intrinsic value of $1326.31, offering a 60% margin of safety — a level value investors typically seek before buying.
Based on Benjamin Graham Formula. Growth rate capped at 25%. For informational purposes only. Not financial advice.
Smart Analysis
HCA Holdings Inc (HCA) · 10 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in market cap, peg ratio, return on equity. Concerns around price/book. Overall metrics suggest strong investment potential with favorable risk/reward.
HCA Holdings Inc (HCA) Key Strengths (6)
Every $100 of shareholder equity generates $136 in profit
Earnings per share surging 44.50% year-over-year
78.44% of shares held by major funds and institutions
Large-cap company with substantial market presence
Good growth relative to its price
Paying $1.44 for every $1 of annual revenue
Supporting Valuation Data
HCA Holdings Inc (HCA) Areas to Watch (4)
Very expensive at 293.4x book value
Modest revenue growth at 6.70%
Thin profit margins with limited profitability
Decent operational efficiency, solid but not exceptional
HCA Holdings Inc (HCA) Detailed Analysis Report
Overall Assessment
This company scores 69/100 in our Smart Analysis, earning a B- grade. Out of 10 metrics analyzed, 6 register as strengths (avg 9.2/10) while 4 fall into concern territory (avg 4.0/10). All four categories (Growth, Profitability, Valuation, and Quality) show healthy scores, indicating broadly sound fundamentals.
The Bull Case
The strongest argument centers on Return on Equity, EPS Growth, Institutional Own.. Valuation metrics including PEG Ratio (1.35), Price/Sales (1.44) suggest the stock is attractively priced. Profitability is solid with Return on Equity at 136.30%. Growth metrics are encouraging with EPS Growth at 44.50%.
The Bear Case
The primary concerns are Price/Book, Revenue Growth, Profit Margin. Some valuation metrics including Price/Book (293.44) suggest expensive pricing. Growth concerns include Revenue Growth at 6.70%, which may limit upside. Profitability pressure is visible in Operating Margin at 16.30%, Profit Margin at 8.97%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Price/Book improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at 136.30% currently healthy but needing to be sustained. Third, growth sustainability, with Revenue Growth at 6.70% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a moderate-to-high risk investment. The weight of evidence leans positive, with more strengths than concerns. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Mixed fundamentals with both positives (Return on Equity, EPS Growth) and negatives (Price/Book, Revenue Growth). A cautious approach is warranted. Monitor for improvement in weak areas before increasing conviction.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
HCA Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
HCA's Price-to-Sales ratio of 1.44x trades 53% above its historical average of 0.94x (92th percentile), historically expensive. The current valuation is 13% below its historical high of 1.66x set in Nov 2025, and 335% above its historical low of 0.33x in Sep 2011. Over the past 12 months, the PS ratio has expanded from ~1.2x, reflecting growing market expectations outpacing revenue growth.
WallStSmart Analysis Synopsis
Data-driven financial summary for HCA Holdings Inc (HCA) · HEALTHCARE › MEDICAL CARE FACILITIES
The Big Picture
HCA Holdings Inc operates as a stable business with moderate growth and solid fundamentals. Revenue reached 75.6B with 7% growth year-over-year. Profit margins are thin at 9.0%, typical for companies in this phase that are reinvesting heavily in growth.
Key Findings
ROE of 13630.0% means the company generates strong returns on shareholder equity. Above 20% is considered top-tier.
Generating 870M in free cash flow and 2.4B in operating cash flow. Earnings are translating into actual cash generation.
What to Watch Next
Margin expansion: can HCA Holdings Inc push profit margins above 15% as the business scales?
Debt management: total debt of 50.2B is significantly higher than cash (1.0B). Monitor refinancing risk.
Sector dynamics: monitor MEDICAL CARE FACILITIES industry trends, competitive moves, and regulatory changes that could impact HCA Holdings Inc.
Bottom Line
HCA Holdings Inc offers stability with moderate growth and solid fundamentals. The valuation may present an opportunity for patient investors, though limited growth means returns will likely come from dividends and modest capital appreciation rather than explosive gains.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions
Loading insider activity...
About HCA Holdings Inc(HCA)
NYSE
HEALTHCARE
MEDICAL CARE FACILITIES
USA
HCA Healthcare is an American for-profit operator of health care facilities that was founded in 1968. It is based in Nashville, Tennessee, and, as of May 2020, owns and operates 186 hospitals and approximately 2,000 sites of care, including surgery centers, freestanding emergency rooms, urgent care centers and physician clinics in 21 states and the United Kingdom.